Acorda Therapeutics, Inc. a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company markets Ampyra , an oral medication to improve gait in patients with multiple sclerosis (MS).
أغلقت الصفقة: تم الوصول لوقف الخسارة:
Nov 22